TABLE 3.
Multivariable logistic regression model evaluating the association between recent donor injection drug use (IDU) and donor culture positivity
| Isolation of bacteria or Candida on donor culture | |||
|---|---|---|---|
| Variable | aOR | 95% CI | p-Value |
| History of recent IDU | 3.65 | 1.06–12.60 | .04 |
| Donor tobacco use | 6.38 | 0.83–48.90 | .07 |
| Donor immunomodulator usea | 0.16 | 0.07–0.37 | <.01 |
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval.
a
Immunomodulators included abatacept, anakinra, apremilast, azathioprine, cyclophosphamide, cyclosporine, denosumab, hydroxychloroquine, methotrexate, mycophenolate, rituximab, secukinumab, sulfasalazine, tocilizumab, tofacitinib, infliximab, adalimumab, certolizumab, golimumab, and etanercept (not including corticosteroids).